In Vitro Validation of a CRISPR-Mediated CFTR Correction Strategy for Preclinical Translation in Pigs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In Vitro Validation of a CRISPR-Mediated CFTR Correction Strategy for Preclinical Translation in Pigs

Published:2019-09-01 Issue:9 Volume:30 Page:1101-1116
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Zhou Zhichang Peter¹²³,Yang Liang Leo¹²,Cao Huibi²,Chen Ziyan Rachel²,Zhang Yiqian²,Wen Xiao-Yan¹³⁴,Hu Jim¹²

Affiliation:

1. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

2. Program of Translational Medicine, The Hospital for Sick Children, Toronto, Canada

3. Zebrafish Centre for Advanced Drug Discovery and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, Canada

4. Department of Medicine, Physiology and Institute of Medical Science, University of Toronto, Toronto, Canada.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/hum.2019.074

Reference59 articles.

1. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene

2. Structure, Gating, and Regulation of the CFTR Anion Channel

3. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection

4. Risk Factors for Bronchiectasis in Children with Cystic Fibrosis

5. Cystic fibrosis

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-Based Therapies: Revolutionizing Drug Development and Precision Medicine;Current Gene Therapy;2024-06

2. The impact of genomic distance on enhancer‐promoter interactions at the CFTR locus;Journal of Cellular and Molecular Medicine;2024-02

3. Advances in applications of the CRISPR/Cas9 system for respiratory diseases;Progress in Molecular Biology and Translational Science;2024

4. CRISPR/Cas9 systems: Delivery technologies and biomedical applications;Asian Journal of Pharmaceutical Sciences;2023-11

5. Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy;Frontiers in Chemistry;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3